WOW – Total transparency gets UCB great info

Very Interesting news from UCB. First I have heard of this strategy. MM&M reports an interesting partnership that is a Win-Win.

UCB announced a partnership with to launch an epilepsy-focused patient community, and will report adverse events to the FDA through round-the-clock surveillance.

The Belgium and Cambridge, MA-based biopharma said in a release that the partnership will create “an online, open epilepsy community” in order to “collect, analyze and reflect information received from people with epilepsy, regardless of their diagnosis, prognosis or treatment regimen.” The online community is expected to launch in early 2010.

Ben Heywood, president and co-founder of, describes the partnership as a win/win situation for patients and industry. “We’re excited to work with a company that has such a depth of knowledge about epilepsy…and provide an opportunity for UCB to better understand the effectiveness of epilepsy drugs across the board,” said Heywood. Full article...

Spread the word. Share this post!